Genetically engineered mouse models (GEMMs) are the backbone of modern preclinical drug development. With the world's largest GEMM repository and a fully integrated CRO platform, GemPharmatech offers researchers an unmatched toolkit for moving from target biology to IND-enabling studies.
In this lunch and learn, Jun Wang, PhD, Senior Scientific Director at GemPharmatech, walks through real preclinical case studies across oncology, metabolic disease, neurology, and immunology — illustrating how model selection, study design, and integrated CRO capabilities translate into more translatable data and more defensible go/no-go decisions.
Speaker Info:
Jun Wang, PhD
Senior Scientific Director
Dr. Jun Wang has over 15 years of experience in biomedical research. Prior to joining GemPharmatech, he served as an Associate Director of Research at Explora Biolabs/Charles River. He has extensive experience with genetically engineered mouse models for drug discovery in various therapeutic areas. Dr. Wang holds a Ph.D. in Developmental Neurobiology from the City of Hope and received his postdoctoral training in pediatric brain cancer research from the Sanford Burnham Prebys Medical Discovery Institute.
Agenda: